Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000591490 | SCV000701501 | pathogenic | not provided | 2016-09-26 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002530966 | SCV003503249 | pathogenic | Autosomal recessive limb-girdle muscular dystrophy type 2D | 2022-05-31 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Ala57Leufs*154) in the SGCA gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SGCA are known to be pathogenic (PMID: 9192266). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with SGCA-related conditions. ClinVar contains an entry for this variant (Variation ID: 497173). For these reasons, this variant has been classified as Pathogenic. |
Genome- |
RCV002530966 | SCV003931638 | pathogenic | Autosomal recessive limb-girdle muscular dystrophy type 2D | 2023-02-08 | criteria provided, single submitter | clinical testing |